ARKEMA S/ADR - ARKAY STOCK NEWS

On November 30, 2021, Arkema reported a total of 76,736,476 shares outstanding. The total number of voting rights, including shares held by the company, is 87,661,718, while the number excluding these shares stands at 84,882,120. This disclosure highlights the company’s voting structure, which is significant for shareholders and potential investors monitoring corporate governance aspects.

Arkema announces the appointment of Armand Ajdari as its new Chief Technology Officer, effective January 1, 2022. Reporting to Chairman and CEO Thierry Le Hénaff, Ajdari will be integral to the company's focus on innovation and sustainable solutions. He brings over 30 years of R&D experience from Saint-Gobain, enhancing Arkema's ambition to become a leader in Specialty Materials by 2024. The company reported sales of approximately €8 billion in 2020 and aims to strengthen its position in the materials market.

Arkema has executed a share buyback program, repurchasing 2,726,829 shares for €300 million between May 21, 2021 and November 24, 2021. Of these, 276,394 shares totaling €30 million are designated for employee share plans, while 2,450,435 shares will be cancelled in Q1 2022. This strategic move is part of Arkema's commitment to enhancing shareholder value as it transitions to a focus on Specialty Materials, which accounted for 82% of sales in 2020.

Arkema has announced its share buyback transactions from November 22 to 26, 2021, in accordance with EU regulations. A total of 93,254 shares were repurchased at a weighted average price of €124.1473 per share. The transactions reflect Arkema's commitment to shareholder value and efficient capital management. Detailed transaction data, including individual buyback amounts and prices, is publicly available on the Group's website.

Arkema announced the execution of share buyback transactions from November 15 to November 19, 2021, as part of its market strategy. A total of 95,000 shares were repurchased at a weighted average price of 122.7829 EUR. These transactions are in compliance with Article 5 §2 of Regulation (EU) No 596/2014, demonstrating Arkema's commitment to shareholder value. The transactions took place across multiple trading days and markets, highlighting a structured approach towards share repurchase activities.

Arkema inaugurates the Christian Collette Center of Excellence for batteries at its Pierre-Bénite Research Center, increasing Kynar® PVDF fluoropolymer production capacity by 50% to meet rising demand for lithium-ion battery materials. The Group targets €1 billion in battery sales by 2030. This investment aligns with its strategy to leverage opportunities in clean mobility and battery technologies, supported by State funding under the France Relance plan. The center aims to accelerate the development of advanced battery materials.

Arkema has conducted share buyback transactions from November 8 to November 12, 2021, in compliance with EU regulations. A total of 46,278 shares were repurchased at a weighted average price of €119.1751. Specific transactions included 4,717 shares at €116.9599 on November 8, and 23,000 shares at €118.1961 on November 9. This buyback initiative could impact the share price and improve shareholder value by reducing the number of outstanding shares.

Arkema announced its share capital and voting rights details as of October 31, 2021. The company currently has a total of 76,736,476 shares outstanding, with 87,310,191 voting rights (including shares held by the company) and 84,648,406 voting rights (excluding shares held by the company). This data indicates the company's governance structure and shareholder engagement metrics, providing valuable insights for investors looking at its stock performance.